IRCT20130812014333N212招募中Unknown
Evaluation of the results of using the ERAS protocol in the process of recovery of children in need ofcolostomy reversal referred to Isfahan
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 day 至 15 years（—）
- 性别
- All
入选标准
- •Age between 1 day and 15 years
- •Patients who are candidates for colostomy surgery
- •Consent of patients or their parents
排除标准
- •Underlying disease that leads to tissue repair impairments (such as sever malnutrition or connective tissue disease)
研究者
相似试验
尚未招募
不适用
Comparing current hospital practices with a new fifteen point system to increase patient satisfaction and shorten hospital stay after head and neck cancer operationsCTRI/2023/02/049533Dr Shagun Bhatia Shah
已完成
Unknown
Effectiveness of Erector spina plane block, Effectiveness of Thoracic epidural anesthesiaIRCT20230314057715N1Shahid Beheshti University of Medical Sciences76
未知
4 期
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Long-Term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease as Measured by Intravascular UltrasonographyHypercholesteremiaJPRN-jRCT1080220348AstraZeneca/Shionogi
进行中（未招募）
1 期
PROTOCOL RET-D-001: EFFICACY AND SAFETY OF SPARSENTAN (RE-021), A DUAL ENDOTHELIN RECEPTOR AND ANGIOTENSIN RECEPTOR BLOCKER, IN PATIENTS WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS): A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL, DOSE-ESCALATION STUDYFOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)MedDRA version: 17.1Level: PTClassification code 10067757Term: Focal segmental glomerulosclerosisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2014-002358-38-BERetrophin, Inc100
进行中（未招募）
不适用
PROTOCOL RET-D-001: EFFICACY AND SAFETY OF SPARSENTAN (RE-021), A DUAL ENDOTHELIN RECEPTOR AND ANGIOTENSIN RECEPTOR BLOCKER, IN PATIENTS WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS): A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL, DOSE-ESCALATION STUDYFOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)MedDRA version: 17.1Level: PTClassification code 10067757Term: Focal segmental glomerulosclerosisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2014-002358-38-ITRetrophin, Inc100